Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial

Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial

Bibliographic Details
Main Authors:	Zacharenia Kallinikou, Diego Arroyo, Mario Togni, Sonja Lehman, Noé Corpataux, Malica Cook, Olivier Müller, Gérard Baeriswyl, Jean-Christophe Stauffer, Jean-Jacques Goy, Serban-George Puricel, Stéphane Cook
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2016-01-01
Series:	Swiss Medical Weekly
Subjects:	bioresorbable vascular scaffold coronary artery disease drug-eluting stent optical coherence tomography
Online Access:	https://www.smw.ch/index.php/smw/article/view/2139

Similar Items

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
by: Beytullah Cakal, et al.
Published: (2020-12-01)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
by: Piotr Desperak, et al.
Published: (2020-04-01)

Clinical and angiographic outcomes at more than 1 year after treatment of chronic total occlusions with the everolimus-eluting bioresorbable vascular scaffold
by: Aylin Hatice Yamac, et al.
Published: (2016-12-01)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
by: Carlo A. Pivato, et al.
Published: (2022-03-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

One-Year Outcome of Everolimus-Eluting Stents versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
by: Mohammad Alidoosti, et al.
Published: (2016-10-01)

Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study
by: T. M. Hommels, et al.
Published: (2019-03-01)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.
by: Da Hyon Lee, et al.
Published: (2017-01-01)

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS
by: T. M. Hommels, et al.
Published: (2020-10-01)

Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010-09-01)

A Challenging Case of Bifurcation Lesion in Left Anterior Descending Artery: Managed Successfully with Everolimus-Eluting Bioresorbable Vascular Scaffold and Kissing Balloon Technique under Optical Coherence Tomography Guidance
by: Sridhar Kasturi, et al.
Published: (2015-01-01)

Everolimus-eluting stents in interventional cardiology
by: Townsend JC, et al.
Published: (2012-06-01)

One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction.
by: Yongcheol Kim, et al.
Published: (2020-01-01)

COMPARATIVE ANALYSIS OF THE INFLAMMATORY RESPOND OF THE VASCULAR WALL AFTER IMPLANTATION OF BIORESORBABLE SCAFFOLDS AND EVEROLIMUS COVERED STENTS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
by: N. A. Musikhina, et al.
Published: (2019-02-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
by: Matthew G. Whitbeck, et al.
Published: (2013-01-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
by: Matthew G. Whitbeck, et al.
Published: (2013-07-01)

Long-Term Follow-Up of Patients after Percutaneous Coronary Intervention with Everolimus-Eluting Bioresorbable Vascular Scaffold
by: Rafael Alexandre Meneguz-Moreno, et al.

Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
by: Le Ni, et al.
Published: (2020-01-01)

Everolimus-eluting stents: update on current clinical studies
by: Allocco DJ, et al.
Published: (2011-07-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
by: Michał Hawranek, et al.
Published: (2021-12-01)

Clinical presentation does not affect acute mechanical performance of the Novolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography
by: Niklas Boeder, et al.
Published: (2021-09-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Correction to: One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
Published: (2022-08-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents.
by: Matthijs A Velders, et al.
Published: (2014-01-01)

Drug-eluting, balloon-expandable, bioresorbable vascular scaffolds reduce neointimal thickness and stenosis in an animal model of percutaneous peripheral intervention
by: Rym El Khoury, MD, et al.
Published: (2023-01-01)

Effects of Everolimus-Eluting Stents on the Left Ventricular Systolic and Diastolic Functions
by: MohammadSadegh Parsaee, et al.
Published: (2015-10-01)

One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
by: Nabijon P. Yuldashev, et al.
Published: (2018-03-01)

Bioresorbable scaffolds vs. drug-eluting stents for patients with myocardial infarction: A systematic review and meta-analysis of randomized clinical trials
by: Yong Liu, et al.
Published: (2022-10-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents.
by: Matthijs A. Velders, et al.
Published: (2013-01-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
Published: (2013-01-01)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
by: Raghav Sharma, et al.
Published: (2022-02-01)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01)

Study to assess clinical outcomes of an everolimus-eluting stent (EES) versus a sirolimus-eluting stent (SES)
by: Amit Madaan, et al.
Published: (2015-12-01)

Bioresorbable scaffolds vs. drug-eluting stents on short- and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis
by: Yan-di Wan, et al.
Published: (2022-09-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
by: Walid Maamoun
Published: (2013-09-01)

Long-term safety and absorption assessment of a novel bioresorbable nitrided iron scaffold in porcine coronary artery
by: Jian-Feng Zheng, et al.
Published: (2022-11-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
by: Juntao Yin, et al.
Published: (2023-01-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
by: Imad Sheiban, et al.
Published: (2008-02-01)

Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
by: Stone, GW, et al.
Published: (2016)